Role of Circadian Neuroendocrine Rhythms in the Control of Behavior and PhysiologyUrbanski H.F.
Division of Neuroscience, Oregon National Primate Research Center, Department of Behavioral Neuroscience and Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oreg., USA Corresponding Author
Henryk F. Urbanski
Division of Neuroscience
Oregon National Primate Research Center
505 N.W. 185th Avenue, Beaverton, OR 97006 (USA)
Tel. +1 503 690 5306, E-Mail email@example.com
Hormones play a major role in regulating behavior and physiology, and their efficacy is often dependent on the temporal pattern in which they are secreted. Significant insights into the mechanisms underlying rhythmic hormone secretion have been gained from transgenic rodent models, suggesting that many of the body’s rhythmic functions are regulated by a coordinated network of central and peripheral circadian pacemakers. Some neuroendocrine rhythms are driven by transcriptional-posttranslational feedback circuits comprising ‘core clock genes’, while others represent a cyclic cascade of neuroendocrine events. This review focuses on recent data from the rhesus macaque, a non-human primate model with high clinical translation potential. With primary emphasis on adrenal and gonadal steroids, it illustrates the rhythmic nature of hormone secretion, and discusses the impact that fluctuating hormone levels have on the accuracy of clinical diagnoses and on the design of effective hormone replacement therapies in the elderly. In addition, this minireview raises awareness of the rhythmic expression patterns shown by many genes, and discusses how this could impact interpretation of data obtained from gene profiling studies, especially from nocturnal rodents.
© 2011 S. Karger AG, Basel
Most organisms live in an environment that changes rhythmically. Some of these changes occur with a period of approximately 1 day (circadian), while others (seasonal) are much slower and occur gradually. Examples include rhythmic alterations in available light, ambient temperature and food availability, and to survive and reproduce under such changing conditions organisms have evolved various physiological adaptations that rely on internal clocks for their coordination. Furthermore, rhythmic output from these biological clocks enables temporal compartmentalization of biochemical processes, which like spatial compartmentalization enables many proteins to perform their cellular functions more effectively.
In mammals, the central circadian clock, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, receives direct neuronal signals from photoreceptors located in the retina, and under normal conditions it is synchronized to the light-dark cycle. GABA and vasoactive intestinal peptide are thought to coordinate the synchronized firing of SCN neurons, which are capable of relaying circadian signals to other tissues, either through direct autonomic innervations or through humoral pathways involving vasopressin as an intermediary [1,2,3,4,5]. Although the SCN clearly serves as a master circadian pacemaker, genetic components of the underlying clock mechanism have been detected in other brain regions as well as most peripheral organs. This raises the possibility that circadian physiology is ultimately controlled by a hierarchy of circadian oscillators synchronized by the SCN, rather than by a single central circadian clock [4,7].
Major advances in our knowledge about the circadian clock mechanism have been made through the use of transgenic knockout rodent models [7,8,9,10,11]. In its essence, this central clock consists of autoregulatory transcriptional-posttranslational feedback loops. Genes encoding Period (Per1 and Per2) and Cryptochrome (Cry1 and Cry2) are activated by a dimer comprising Bmal1 and other PAS-domain proteins Clock or Npas2. In turn, Per and Cry proteins enter the cell nucleus where they ultimately inhibit activation of their own genes. Ancillary feedback loops involving Rev-erbα and Rora, as well as casein kinases (CKIε and CKIδ), serve to stabilize the circadian rhythmicity.
In contrast to these well-documented advances in basic chronobiology, clinical applications have been slow. On the one hand, the existence of endogenous biological clocks has been known for many centuries . In addition, knowledge of circadian rhythms has been used to develop therapies for jetlag and seasonal affective disorder [13,14,15]. On the other hand, because of difficulties in maintaining human subjects under carefully controlled environmental conditions and difficulty in performing human gene expression studies, it is unclear if perturbed biological rhythms have a much more widespread impact on human physiology, especially during aging. Moreover, general clinical practice rarely takes underlying biological rhythms into consideration. For example, the diagnosis of hormone levels is often based on infrequent blood samples collected at inappropriate times of day, and therapeutic administration of hormones often follows non-physiological paradigms.
Because endocrine rhythms play a major role in regulating behavioral and physiological functions, it is likely that their perturbation contributes to the etiology of various human pathologies [16,17,18,19,20,21]. However, progress in understanding the underlying causal mechanisms has been hampered by the lack of suitable experimental animal models. On the one hand, rodents have proven to be excellent models for systematically dissecting the biochemical components that constitute the central circadian clock and it primary outputs, but their clinical translational potential is limited. Not only are they nocturnal, but they do not show consolidated sleep-wake patterns, Furthermore, the patterns of hormone secretion from their adrenal glands and gonads differ significantly from those of humans. This review tries to fill the gap in our knowledge by focusing on rhesus macaques (Macaca mulatta), which like humans are large, long-lived diurnal species and show similar consolidated sleep-wake patterns. Importantly from a women’s health perspective, female rhesus macaques have similar menstrual cycles and show similar age-related changes in their reproductive and adrenal neuroendocrine axes [22,23,24,25]. In this mini-review, recent data from rhesus macaques are used to illustrate the dynamic nature of hormone secretion, and the implication of these findings for clinical and basic research is discussed.
Rhesus macaques can be readily maintained under a tightly-controlled environment (e.g. photoperiod, temperature, diet, and medication), thereby eliminating the extraneous variables and selection bias that are unavoidable in human clinical trials. Furthermore, because they are large, they readily lend themselves to serial blood collection, using an implanted vascular catheter and a swivel-based remote sampling system [26,27]. Importantly, this enables blood samples to be repeatedly collected from minimally restrained, non-sedated animals across the day and night, even when they are asleep; this can then be used to establish detailed 24-hour plasma hormone profiles. By simultaneously monitoring motor activity in the animals (e.g. using Actiwatch recorders; Philips-Respironics, Bend, Oreg., USA), the phase of the underlying hormone rhythms can be readily linked to the animal’s circadian activity-rest cycle.
Circadian rhythms are defined as self-sustainable cyclic events that have a periodicity of approximately 24 h. Overt examples include daily cycles of activity-rest, alertness-sleep, and body temperature. Although these rhythms are usually entrained to an environmental cue (Zeitgeber), such as the daily light-dark cycle, many of them continue to be expressed even when environmental conditions are held constant [28,29]. In the rhesus macaque, like other mammals, many hormones have a 24-hour rhythm. However, not all of these rhythms are self-sustaining. For example, in humans, circulating growth hormone levels show a daily nocturnal peak, but this is not a true circadian rhythm because the peak stems directly from being asleep . Similarly, the 24-hour prolactin rhythm is generally coupled to the sleep-wake cycle, although there is evidence for an underlying circadian rhythm component [30,31,32]. In contrast, adrenal steroids such as cortisol, dehydropiandrosterone (DHEA) and DHEA sulfate (DHEAS) not only have robust 24-hour patterns of release in rhesus macaques, but also they are self-sustaining, that is they continue to be clearly expressed even when the animals are maintained under continuous dim illumination. An example of this self-sustained rhythmicity is illustrated in figure 1. The motor activity data depicted in figure 1a were obtained from an adult rhesus macaque using an Actiwatch, and emphasize the highly entrained diurnal pattern of activity that occurs under fixed 12L:12D photoperiods [33,34,35,36]. In addition, the data show how the activity rhythm becomes free-running, with slight phase advancement, when the animal is exposed to continuous dim illumination (30 lx). Serial blood samples were remotely collected while the animals were maintained under the continuous dim illumination [26,27] and the plasma was assayed for cortisol and DHEAS; in both cases, 24-hour circadian rhythms were evident despite the absence of photoperiodic cues. Importantly, both of these hormones showed a peak that was associated with the onset of activity and a nadir that was associated with the onset of rest. The significance of the distinction between 24-hour and circadian hormone rhythms is that the latter are more likely to be regulated by a circadian molecular clock mechanisms and may act as auxiliary circadian pacemakers, helping to synchronize various physiological functions .
DHEAS and cortisol are both produced by the adrenal cortex and are two of the most abundant steroids in the circulation of adult humans and non-human primates. In both species, circulating DHEAS shows a profound age-related decrease [38,39,40,41,42]; this dramatic change is illustrated in figure 2, with respect to male rhesus macaques. In contrast, plasma cortisol levels do not show a decline and a clear 24-hour rhythm is still evident well into old age (fig. 2). Importantly, the age-related elevation of the cortisol baseline means that brain and peripheral organs, such as the liver, do not get a complete break from exposure to cortisol, which may predispose the elderly to insomnia and as well as to metabolic disorders. The exact physiological significance of an age-associated decrease in plasma DHEA and DHEAS levels is unclear. However, these steroids can attenuate the deleterious effects of cortisol and so the age-associated decline in DHEA:cortisol ratio is thought to underlie cognitive decline [43,44]. Additionally, lower levels of DHEA and DHEAS have been associated with cognitive disorders with a higher prevalence in the elderly, such as Alzheimer’s disease  and depression . In healthy old men  and postmenopausal women , elevated endogenous DHEAS levels have been linked to better cognitive performance. While studies of the frail elderly showed an inverse relationship between DHEAS and cognitive ability [48,49], a comparable study in non-human primates failed to disclose a similar association . This difference in response could be due to the fact that frail non-human primates are usually not included in experiments, or that the timing of the single daily blood samples did not correspond to the animals’ circadian hormonal peak. In addition to direct actions within the central nervous system, DHEA and DHEAS may exert some of their beneficial effects indirectly, via intracrine conversion to sex steroids [51,52]. Many organs, including the brain, appear to express the enzymes necessary for this conversion, and it is well established that sex steroids can exert neuroprotective effects in brain areas such as the hippocampus . Because estrogen can improve cognitive function and influence gene expression in various regions of the macaque brain [54,55,56,57,58], it is plausible that DHEA and DHEAS mediate some of their central actions via conversion to estrogen. It is also plausible that the age-related loss of humoral circadian signaling due to attenuated DHEA and DHEAS levels contributes to age-related desynchronization of peripheral oscillators and exacerbation of circadian dissonance in the elderly.
The adipocyte-derived hormone, leptin, has been shown to have a 24-hour rhythm, with a nocturnal peak, in both lean and obese humans, as well as in individuals with type 2 diabetes [59,60,61]. Recent studies using rhesus macaques have shown that this rhythm is circadian, because it persists even under continuous dim illumination . Interestingly, the rhythm is still evident in old male macaques but in peri- and postmenopausal females the difference between day- and nighttime plasma leptin levels becomes minimal. Because leptin is generally associated with suppression of appetite it makes biological sense for its peak to occur at night, which is when humans and rhesus macaques usually sleep. On the other hand, the physiological relevance of an age-related decline is unclear. One possibility is that disruption of the circadian leptin rhythm contributes to the development of metabolic disorders and obesity [63,64,65,66] and interferes with the maintenance of bone mass [67,68].
Another hormone that shows a pronounced 24-hour rhythm in both men [69,70,71] and adult male rhesus macaques [72,73,74] is testosterone. Like leptin, the plasma testosterone rhythm shows a nocturnal peak and is associated with sleep (fig. 3a, b); this contrasts with the timing of the daily cortisol and DHEAS peaks, which occur in the morning in association with onset of activity (fig. 1, 2). In this particular study the blood samples were remotely collected at 30-min intervals for 24 h, and the testosterone profiles depict mean values from 10 animals. Although the 24-hour rhythm is clearly evident there is much underlying fluctuation in the testosterone levels because this steroid is released in an episodic manner that corresponds to the underlying ultradian pattern of LH release . Consequently, it is extremely difficult to accurately assess testicular endocrine function, or diagnose age-related changes, in individuals based on single time point testosterone measurements. Instead, multiple samples need to be collected, and ideally as close to the nocturnal peak as possible [72,73,74,75].
In humans, seasonal variations have been reported for blood pressure, immune response, birth rate, and sleep duration, as well as for behavioral traits associated with seasonal affective disorders, bulimia nervosa, anorexia, and suicide [76,77,78,79,80]. Although the underlying neuroendocrine mechanisms are unclear they are thought to be linked to seasonal circadian neuroendocrine changes. In this context, the pineal hormone, melatonin, has been the most widely studied, because its circadian pattern of release is markedly affected by the photoperiod . As winter approaches, the duration of the night period becomes longer, causing more melatonin to be secreted. This provides a useful neuroendocrine cue that environmental conditions are changing, and this is exploited by temperate zone mammals to initiate various physiological adaptations. For example, long-day breeding species, such as hamsters and voles, rely on the short-day melatonin profile to terminate their breeding season. In contrast, larger species with a gestation periods of 5–6 months, such as sheep and deer, use it to initiate their breeding season. When maintained under natural photoperiods, rhesus macaques also show seasonal reproductive cycles with breeding confined to the autumn and winter [81,82,83]. In the males, testicular size and serum testosterone levels are markedly lower during the non-breeding season (fig. 4). Importantly, however, if the animals are housed indoors under fixed 12L:12D photoperiods they do not show an annual decrease in these reproductive parameters, instead they maintain large testes and elevated testosterone throughout the year, like men [84,85,86,87,88]. This suggests that some seasonal neuroendocrine rhythms might simply represent direct responses to changing environmental cues, or to a chain of neuroendocrine events that are analogous to those comprising the menstrual cycle, rather than being driven by a circannual intracellular molecular clock mechanism.
Because adrenal steroids play a major role in regulating behavior and physiology, their seasonal profiles have received much attention. However, the human data for cortisol are largely inconclusive. Some studies have reported seasonal differences [89,90,91,92,93], whereas others have failed to do so [94,95,96,97]. Similarly, some studies have reported seasonal differences in DHEAS levels [98,99,100], whereas one study found none . In a recent examination of 24-hour plasma cortisol or DHEAS profiles of ovariectomized rhesus macaques, no effect of photoperiod was found on the mean or peak hormone levels. However, there was a marked phase advancement of both hormonal rhythms in short days, reflecting a similar phase advancement of the daily motor activity rhythm . Furthermore, significant differences were detected in the gene expression profiles of the adrenal gland under different photoperiodic conditions. Together, these data reinforce the view that normal behavior and physiology is dependent on the maintenance of specific phase relationships between different neuroendocrine rhythms , and that these relationships may change under different environmental conditions, as well as during aging.
Gene expression profiling in the rhesus macaque adrenal gland, using Affymetrix GeneChip arrays, has shown that many of the genes associated with rhythmic production of adrenal steroids have a rhythmic 24-hour expression profile, and that the adrenal gland itself expresses a circadian core-clock mechanism similar to that expressed in the SCN . Equally important, a significant number of the genes showed a 24-hour expression pattern; some of these genes showed a peak of expression in the middle of the night while others showed a peak in the middle of the day (fig. 5). Subsequent studies showed that day length can also influence the expression of a wide variety of genes in the rhesus macaque adrenal gland  (fig. 6). Some of the main genes affected by a 4-hour photoperiodic change included those associated with development, metabolism and immune function (fig. 6, lower panels). Other rhesus macaque studies have shown that gene expression within the rhesus macaque brain can be significantly affected by ovarian steroids, and hence by the phase of the menstrual cycle . Together, these findings emphasize the importance of collecting terminal tissue samples at the most appropriate time of the day, month, or season. This, however, can be problematic as some genes of interest may show a peak of expression in the middle of the night while others may show a peak in the middle of the day. Consequently, if necropsies are performed on experimental animals exclusively during the daytime, when some genes are exhibiting a nadir in their expression rhythm, important changes could be missed . Furthermore, the situation is compounded when making inferences from rodent studies to those of humans, because daytime necropsies correspond to the subjective night of nocturnal rodents but to the subjective day of rhesus macaques and humans. Awareness of neuroendocrine rhythms, and the underlying rhythmic expression of many genes, represents a key aspect of effective experimental design.
In humans, almost all behavioral and physiological functions occur on a rhythmic basis . Given that hormones play a key role in the cross-talk between different systems, it is likely that perturbation of their rhythmic release contributes to the pathophysiology of a wide range of human disorders, especially during aging [40,103,104,105,106]. Before appropriate hormone supplementation or pharmaceutical intervention is prescribed, it is imperative that the underlying perturbed hormone levels are correctly identified. This may require collection of serial blood samples at specific times of the day, phase of menstrual cycle as well as time of year.
For example, with reference to testosterone rhythm depicted in figure 3, if blood samples are collected in the late afternoon they are likely to show lower testosterone concentrations than samples collected in the early morning. Furthermore, unless several blood samples are collected there is a high risk of missing one of the underlying ultradian testosterone pulses, thereby leading to further underestimation of testosterone production and release. The situation can be even more complicated if the individual has just returned from a long trip and is suffering from lag, or if he is a nightshift worker; in both cases the individual’s testosterone rhythm could be significantly phase shifted and so the early morning may no longer be the most appropriate time of day for the collection of serial blood samples. This has important clinical implications, because in male rhesus macaques [72,73] and men [107,108,109,110,111,112] circulating testosterone levels decline during aging. Whether this decline represents a male andropause  is questionable because the age-related decline in testosterone levels is less abrupt or severe than the decline in ovarian steroids that occurs during female menopause [23,25], also the functional significance of a moderate age-related testosterone decline remains to be elucidated. Nevertheless, it is plausible that a well-defined nocturnal testosterone peak contributes to the overall maintenance of circadian physiology, including sleep patterns. Consequently, clinical treatment of low testosterone levels through androgen supplementation should ideally follow the underlying physiological 24-hour profile. For practical reasons, this is rarely the case, however. Common androgen supplementation paradigms typically involve long-term continuous release capsules, which have the advantage of low maintenance but which completely obliterate the 24-hour rhythm. Other paradigms involve cyclic transdermal delivery of testosterone, via the daily application of gels. However, these are generally applied in the morning rather than at night, to avoid accidental transfer of the steroid to a sleeping partner; unfortunately, this means that the daily plasma testosterone peak generated by the gel can be markedly out of phase with the endogenous testosterone rhythm. The long-term impact of these non-physiological androgen supplementation paradigms is unclear, and alternative approaches may prove to be more beneficial to overall physiology. An interesting novel approach has recently been demonstrated in men [114,115], which involves oral administration of micronized testosterone in sesame oil. Normally, orally administered testosterone has little physiological potency because after being taken up by the gut it is immediately transported to the liver via the hepatic portal vein and then passes back into the gut rather than into the general circulation. It appears that much of this enterohepatic circulation of testosterone can be bypassed if the steroid is mixed with sesame oil. Although the exact mechanism is unclear, it may involve preferential absorption by the lymphatics, bypassing the liver and reaching the circulation via the thoracic duct. Studies have shown that this administration paradigm can more closely mimic the natural 24-hour plasma testosterone rhythm [114,115].
Similarly, for DHEAS one would expect there to be an optimal time of day for supplementation of this hormone in the elderly. In the USA, DHEA is widely available to the public without prescription as a dietary supplement. DHEA is readily converted to DHEAS and vice versa by sulfyl transferase and steroid sulfatase enzymes, respectively, and because it has a much shorter half-life than DHEAS it shows a more pronounced 24-hour rhythm . With reference to the DHEAS rhythm depicted in figures 1 and 2, it is clear that early morning supplementation with exogenous DHEA represents a more physiological paradigm than a similar DHEA dose in the early evening, and consequently morning DHEA supplementation is more likely to harmonize with the body’s circadian physiology.
This work was supported by National Institutes of Health Grants AG-029612, AG-036670, HD-029186 and RR-000163.
Henryk F. Urbanski
Division of Neuroscience
Oregon National Primate Research Center
505 N.W. 185th Avenue, Beaverton, OR 97006 (USA)
Tel. +1 503 690 5306, E-Mail firstname.lastname@example.org
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.